Novartis Indonesia and Indonesian Ministry of Health Signed an MOU for Non-Communicable Disease Control

We are proud to announce that on May 7th, 2021, Novartis Indonesia and the Ministry of Health of Republic of Indonesia had signed a Memorandum of Understanding (MoU) in the area of Non-Communicable Disease Control.  Khalid Ibrahim, President Director of Novartis Indonesia signed the MOU together with drg. Oscar Primadi MPH, Secretary General of the Ministry of Health of Republic of Indonesia.

This marked the fourth MoU Novartis Indonesia have signed with the Ministry of Health and one of the true demonstration of our commitment in re-imagine medicine; to improve healthcare system and our patients’ quality of life, through collaboration and partnership with our respective stakeholders.

Non-Communicable Diseases (NCD) has become one of the major health problems and highest cause of death in Indonesia. Through this MoU, we will be strengthening the cross-sector synergy, between public and private to improve the health outcomes.

This partnership will bring a significant contribution in strengthening Indonesia healthcare system, and most importantly to help patients in Indonesia to get better quality of life.

For your information an article published in the Ministry of Health’s official website in below link:

https://sehatnegeriku.kemkes.go.id/baca/berita-utama/20210507/3437732/kemenkes-pt-novartis-indonesia-jalin-kerja-sama-bidang-pengendalian-penyakit-tidak-menular/